PURPOSE OF REVIEW: Pediatric uveitis is relatively uncommon, accounting for only 5-10% of all patients with uveitis. However, owing to high prevalence of complications and devastating outcomes, its lifetime burden can be significant. RECENT FINDINGS: Immunomodulatory therapy has been associated with better outcomes in noninfectious pediatric uveitis. However, effective treatments are limited by medication-related complications, including multiorgan toxicities and systemic side effects. SUMMARY: We review the current therapies available to treat pediatric uveitis, discuss novel and future therapies, and provide clinical recommendations utilizing these new agents. The consideration for treatment regimens in noninfectious pediatric uveitis is multifactorial. Understanding past, present, and future technology will aid in treatment of a complex and refractory disease.
PURPOSE OF REVIEW: Pediatric uveitis is relatively uncommon, accounting for only 5-10% of all patients with uveitis. However, owing to high prevalence of complications and devastating outcomes, its lifetime burden can be significant. RECENT FINDINGS: Immunomodulatory therapy has been associated with better outcomes in noninfectious pediatric uveitis. However, effective treatments are limited by medication-related complications, including multiorgan toxicities and systemic side effects. SUMMARY: We review the current therapies available to treat pediatric uveitis, discuss novel and future therapies, and provide clinical recommendations utilizing these new agents. The consideration for treatment regimens in noninfectious pediatric uveitis is multifactorial. Understanding past, present, and future technology will aid in treatment of a complex and refractory disease.
Authors: Clive Edelsten; Vickie Lee; Christopher R Bentley; Jack J Kanski; Elizabeth M Graham Journal: Br J Ophthalmol Date: 2002-01 Impact factor: 4.638
Authors: Manuel Díaz-Llopis; David Salom; Carmen Garcia-de-Vicuña; Miguel Cordero-Coma; Gabriela Ortega; Norberto Ortego; Marta Suarez-de-Figueroa; Maria J Rio-Pardo; Carlos Fernandez-Cid; Alex Fonollosa; Ricardo Blanco; Angel M Garcia-Aparicio; Jose M Benitez-Del-Castillo; Jose L Olea; J Fernando Arevalo Journal: Ophthalmology Date: 2012-04-21 Impact factor: 12.079
Authors: Roberto Gallego-Pinazo; Rosa Dolz-Marco; Sebastián Martínez-Castillo; J Fernando Arévalo; Manuel Díaz-Llopis Journal: Inflamm Allergy Drug Targets Date: 2013-02
Authors: E Marrani; R Cimaz; O M Lucherini; R Caputo; A Vitale; L Cantarini; G Simonini Journal: Pediatr Rheumatol Online J Date: 2015-10-06 Impact factor: 3.054
Authors: Cristina Alvarez-Peregrina; Clara Martinez-Perez; Miguel Ángel Sánchez-Tena Journal: Int J Environ Res Public Health Date: 2022-07-22 Impact factor: 4.614